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Dear Editor,
Serum- and feeder-free culture conditions have received a
great deal of attention for culturing human embryonic stem
(hES) cells or induced pluripotent stem (iPS) cells although
hES/iPS cells are still most commonly maintained on
inactivated mouse embryonic fibroblast feeders (MEF) in
medium supplemented with FBS (Thomson et al. 1998;
Reubinoff et al. 2000), or proprietary replacements, such as
knockout serum replacement (KSR) together with fibroblast
growth factor-2 (FGF-2) (Amit et al. 2000; Draper et al.
2004). Use of culture media containing undefined or
undisclosed components has limited the development of
applications for pluripotent cells because of our lack of
knowledge of their responses to specific cues that control
self-renewal, differentiation, and lineage selection. There-
fore, a defined serum-free medium consisting of minimum
essential components for culturing hES/iPS cells could
contribute to advances in the field.
Previously, we have developed a defined growth factor-
supplemented serum-free medium, hESF9, for the culture
of human ES cells on a type I collagen substrate without
feeders (Furue et al. 2008). This medium consists of hESF
basal medium supplemented with heparin and only four
protein components: insulin, transferrin, albumin conjugat-
ed with oleic acid, and FGF-2 (10 ng/ml). Under these
culture conditions, FGF-2 promotes proliferation of hES
cells in a concentration-dependent manner. Heparin, which
is known to enhance the activity of FGF, also promotes
proliferation of hES cells in a concentration-dependent
manner in the absence of FGF-2 suggesting that endoge-
nous FGF-2 is produced by hES cells. In conventional
cultures with KSR-based medium, the proliferative effects
of FGF-2 or heparin are not detectable although it is well
known that FGF-2 supports hES cell growth. Thus, a
defined serum-free medium consisting of minimum essen-
tial components could aid in elucidating hES/iPS cell
responses to specific cues that control self-renewal, differ-
entiation, and lineage selection.
The modern era of serum-free growth began in the mid-
1970s when Izumi Hayashi and Gordon Sato (1976)
defined conditions for growth of a rat pituitary cell line in
a hormonally defined serum-free medium that did not alter
cell phenotypes or cell growth. N2 supplements for neural
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DOI 10.1007/s11626-010-9317-zcells were developed by Bottenstein and Sato (1979). Later,
we described a variety of serum-free media that can be used
to propagate and analyze differentiated cells (Barnes and
Sato 1980; Sato 1987; Furue et al. 1994; Okamoto et al.
1996; Sato et al. 2002). Serum contains variable amounts of
hormones, soluble growth and differentiation factors,
attachment factors, and undefined components. Also MEFs
secrete a variety of nutrients or growth factors most of
which have not been identified. The precise formulation of
KSR is not in the public domain, and although “serum-
free,” it is likely to contain a variety of animal products
(PCT/US98/00467; WO98/30679). The formulations of
several other products for serum-free culture from several
companies are also proprietary. These undefined or dis-
closed components of the culture conditions hamper
analysis of the mechanisms that control cell behavior.
However, there are several difficulties in culturing hES/
iPS cells in defined conditions without MEFs. First,
propagation of pluripotent hES/iPS cells has been difficult
to achieve even in conventional culture media due to their
propensity to differentiate (Skottman and Hovatta 2006;
Adewumi et al. 2007) as most researchers working with
hES/iPS cells know. When cells grown to confluence are
split, many differentiated cells appear in the next passage.
The variability of batches of MEFs or KSR affects the
tendency of cells to differentiate. The dissociation method
is the most problematic. Even in conventional cell culture,
imprecise handling during dissociation decreases cell
survival as single hES/iPS cells cannot survive. Centrifu-
gation at high speed decreases cell survival or promotes cell
aggregation. Unless the cells are handled with care for
several passages on MEFs in KSR-based medium, the cells
do not survive or differentiate when transferred to feeder-
free cultures. We had used EDTA to dissociate hES cell
colonies in the feeder-free culture method using hESF9
medium. As the attachment activity of undifferentiated hES
cells is different from that of differentiated cells, the
undifferentiated hES cells were able to be transferred to
the next passage, which led to the successful continuous
culture of undifferentiated cells. However, this method
requires previous practical experience with human primary
Figure 1. Attachment and proliferation of hES and iPS cells on type I
collagen. The attachment of hES/iPS cells to ECM components was
measured by the procedures followed by Fassler and Meyer (1995).
Briefly, a 96-well microplate (Corning Costar, Corning, NY) was
coated with each adhesion molecule at 37°C for 3 h. hES/iPS cells
were seeded at confluent density (3×10
6cells cm
−2) on type I collagen
(Nitta Gelatin, Inc.) coated plates in hESF9 (Cell Science &
Technology Institute, Inc.). After 3 d, the attached cells were fixed
and stained for 30 min with 0.4% crystal violet (Sigma) in methanol.
After the plate was washed and dried, a solution (1% acetic acid and
30% ethanol in water) was added to the wells to dissolve the crystal
violet. The absorbance of 595 nm, which indicated the concentration
of the dissolved crystal violet, was measured with a microplate reader
(model 550; Bio-Rad, Hercules, CA). Each graph shows the
percentage of the attached cells on type I collagen in hESF9 relative
to the attached cells on fibronectin (Sigma) as 100% as all the cell
lines attached to fibronectin in hESF9. Bar=SE (n=3).
Figure 2. hES cells cultured on fibronectin in hESF9 medium. Phase-
contrast microphotographs of KhES-1 at passage 16 and KhES-3 at
passage 6 cultured on fibronectin in hESF9 medium. After 2 d, the
KhES-1 cells and KhES-3 cells (from Kyoto University) cultured on
MEF in KSR-based medium were passaged by the routine procedure
onto the new MEF; the medium was changed to hESF9 medium, and
then the cells were cultured on MEF for more than 4 d. Previously, we
dissociated the hES cells with EDTA, but some of cell lines could not
survive after the dissociation with EDTA. Then, we have utilized 1 U/
ml dispase (Roche Applied Science) for approximately 1 min at 37°C
to dissociate the hES/iPS colonies into the small clumps. The cells
were washed twice at 20 g and then seeded on fibronectin-coated flask
(Corning Costar) in hESF9 medium.
574 KUSUDA FURUE ET AL.cell cultures. As hESF9 medium consists of minimum
essential components, improper handling greatly affects cell
viability and culture outcome.
Second, there are variations in the characteristics of hES/
iPS cell lines as most of the researchers working on hES/
iPS cells have come to realize. hES cell lines, Shef1, Shef5,
and HUES1 cultured in the University of Sheffield were
able to attach to type I collagen and grow well in hESF9
medium (Furue et al. 2008). However, we found that
attachment activity of the KhES-1 line (Nakatsuji 2005),
which was established in Kyoto University, to type I
collagen seemed low, suggesting that there is a difference
between the cell lines in their attachment ability. Owing to
regulatory issues for hES cell importation into Japan, we
were unable to directly compare KhES-1 cells with Shef1
or HUES1. We have examined the attachment and growth
activity of other hES lines (KhES-3 from Kyoto University,
Kyoto, Japan; H9 from National Stem Cell Bank, WiCell,
Madison, WI) and the MRC-5-derived iPS cell line Tic
(JCRB 1331, JCRB Cell Bank, Osaka, Japan), which was
established in the National Center for Child Health and
Development, on type I collagen (Nitta Gelatin, Osaka,
Japan) in hESF9 medium (Cell Science & Technology
Institute, Sendai, Japan). The results show that there is a
difference between hES/iPS cell lines in attachment activity
to type I collagen. This result suggests that there is a
difference among cell lines in integrin signaling (Fig. 1).
Based on these findings, we have modified the culture
protocol and tried to culture KhES-1 and KhES-3 cell lines
on fibronectin (Sigma, St. Louis, MO) in hESF9 medium
without feeders (Fig. 2). Matrigel, a basement membrane
preparation from the Engelbreth–Holm–Swarm mouse
tumor, is often used for feeder-free culture for hES/iPS
cells with MEF-conditioned medium (Draper et al. 2004).
However, it contains a complex and ill-defined mixture of
fibronectin, laminin, type IV collagen, entactin, and
heparan sulfate proteoglycans, and various growth factors
such as FGF-2, EGF, PDGF, and NGF (Yang et al. 2003).
Ludwig et al. (2006) have reported that in place of matrigel,
a combination of collagen IV, fibronectin, laminin, and
vitronectin supported robust, long-term proliferation of
human ES cells in their chemically defined medium TeSR1.
We have previously reported by using defined serum-free
culture conditions for mouse embryonic stem (mES) cell
that integrins regulate mES cell self-renewal. mES cells
remained undifferentiated when cultured on type I and type
IV collagen or poly-D-lysine whereas they differentiated
when cultured on laminin or fibronectin where LIF-induced
self-renewal signaling was decreased (Hayashi et al. 2007).
Now, we are investigating the role of integrins in the
pluripotency of hES/iPS cells.
For robust cultures, we have further modified the culture
protocol. We have used 1 U/ml dispase (Roche Applied
Science, Indianapolis, IN) to dissociate the cell colonies and
washed the dispase with the medium supplemented with
recombinant human albumin (1 mg/ml, Millipore, Bedford,
MA). If differentiated cells appear in the culture, addition of
low concentration of activin (2∼10 ng/ml, R&D Systems,
Minneapolis, MN) or middle concentration of noggin
(10∼20 ng/ml, R&D Systems) seems also to inhibit the
differentiated cell growth as previously reported (Beattie et al.
2005; James et al. 2005; Vallier et al. 2005;W a n ge ta l .
2005). However, addition of these growth factors confounds
the analysis of the actions of other exogenous factors. We are
using hESF9 medium to develop a drug screening test.
It would be convenient if the cell culture novice could
propagate and passage any type of cell without difficulty.
Unfortunately, this is currently not the case for undiffer-
entiated hES/iPS cell lines. Although serum has proved to
be a universal medium supplement that allowed the
isolation and characterization of a few normal diploid cell
lines and numerous abnormal transformed cell lines over
the years, the use of serum or other undefined medium
components impedes our ability to understand cell
responses to controlled environmental stimuli. There are
advantages and disadvantages to culturing hES/iPS cells
under defined serum-free culture conditions, and the
suitability of any particular medium depends on the
purpose of the experiment.
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